Nicole Boulianne
- Formation
- à venir
Aucune offre active
Autres opportunités de carrière
- Axe principal
- Santé des populations et environnementale
- Adresse
- 2875, boulevard Laurier, Édifice Delta II, 6e étage, bureau 600
Québec (Québec)
CANADA G1V 2M2 - Téléphone
- +1 418-666-7000, poste 235
- Télécopieur
- +1 418-666-2776
- Courriel
- nicole.boulianne@ssss.gouv.qc.ca
Publications récentes (voir toutes les publications de ce chercheur)
Kiely M, Defay F, Sauvageau C, Gilca V, Guay M, Boulianne N, Dube E. [In Process Citation]. Perspective infirmière : revue officielle de l'Ordre des infirmières et infirmiers du Québec,
2012. 9: 61-4
Dube E, Gilca V, Sauvageau C, Bradet R, Lavoie F, Boulianne N, Boucher FD, Bettinger JA, McNeil S, Gemmill I. Acute otitis media and its prevention by immunization: a survey of Canadian pediatricians' knowledge, attitudes and beliefs. Human vaccines,
2011. 7: 429-35
Dube E, Gilca V, Sauvageau C, Bradet R, Bettinger JA, Boulianne N, Boucher FD, McNeil S, Gemmill I, Lavoie F. Canadian paediatricians' opinions on rotavirus vaccination. Vaccine,
2011. Epub
Gilca R, De Serres G, Boulianne N, Ouhoummane N, Papenburg J, Douville-Fradet M, Fortin E, Dionne M, Boivin G, Skowronski DM. Risk factors for hospitalization and severe outcomes of 2009 pandemic H1N1 influenza in Quebec, Canada. Influenza and other respiratory viruses,
2011. 5: 247-55
Heidebrecht CL, Pereira JA, Quach S, Foisy J, Quan SD, Finkelstein M, Deeks SL, Guay M, Bettinger JA, Kolbe F, Crowcroft NS, Sikora CA, Buckeridge DL, Kwong JC, Public Health Agency of Canada/Canadian Institutes of Health Research. Approaches to immunization data collection employed across Canada during the pandemic (H1N1) 2009 influenza vaccination campaign. Canadian journal of public health. Revue canadienne de sante publique,
2011. 102: 349-54
Gilca R, Deceuninck G, De Serres G, Boulianne N, Sauvageau C, Quach C, Boucher FD, Skowronski DM. Effectiveness of pandemic H1N1 vaccine against influenza-related hospitalization in children. Pediatrics,
2011. 128: e1084-91
Gilca V, De Serres G, Hamelin ME, Boivin G, Ouakki M, Boulianne N, Sauvageau C, Dionne M, Gilca R, Skowronski D. Antibody persistence and response to 2010-2011 trivalent influenza vaccine one year after a single dose of 2009 AS03-adjuvanted pandemic H1N1 vaccine in children. Vaccine,
2011. 30: 35-41
Dube E, De Wals P, Gilca V, Boulianne N, Ouakki M, Lavoie F, Bradet R. Burden of acute otitis media on Canadian families. Canadian family physician Medecin de famille canadien,
2011. 57: 60-5
De Wals P, Deceuninck G, Lefebvre B, Boulianne N, De Serres G. Effectiveness of serogroup C meningococcal conjugate vaccine: a 7-year follow-up in Quebec, Canada. The Pediatric infectious disease journal,
2011. 30: 566-9
Dube E, Defay F, Gilca V, Bettinger JA, Sauvageau C, Lavoie F, Boucher FD, McNeil S, Gemmill I, Boulianne N. A(H1N1) pandemic influenza and its prevention by vaccination: paediatricians' opinions before and after the beginning of the vaccination campaign. BMC public health,
2011. 11: 128
